首页 | 本学科首页   官方微博 | 高级检索  
     


Implementing international osteoarthritis treatment guidelines in primary health care: study protocol for the SAMBA stepped wedge cluster randomized controlled trial
Authors:Nina??ster?s  author-information"  >  author-information__contact u-icon-before"  >  mailto:nina.osteras@medisin.uio.no"   title="  nina.osteras@medisin.uio.no"   itemprop="  email"   data-track="  click"   data-track-action="  Email author"   data-track-label="  "  >Email author,Leti?van Bodegom-Vos,Krysia?Dziedzic,Tuva?Moseng,Eline?Aas,?yvor?Andreassen,Ibrahim?Mdala,B?rd?Natvig,Jan?Harald?R?tterud,Unni-Berit?Schjervheim,Thea?Vliet?Vlieland,K?re?Birger?Hagen
Affiliation:1.National Advisory Unit on Rehabilitation in Rheumatology, Department of Rheumatology,Diakonhjemmet Hospital,Oslo,Norway;2.Department of Medical Decision Making,Leiden University Medical Center,Leiden,The Netherlands;3.Arthritis Research UK, Primary Care Centre, Research Institute for Primary Care and Health Sciences,Keele University,Keele,UK;4.Department of Health Management and Health Economics, Institute of Health and Society, Faculty of Medicine,University of Oslo,Oslo,Norway;5.Patient Research Panel, Department of Rheumatology,Diakonhjemmet Hospital,Oslo,Norway;6.Department of General Practice, Institute of Health and Society,University of Oslo,Oslo,Norway;7.Department of Orthopaedic Surgery,Akershus University Hospital,L?renskog,Norway;8.Health and Social Services,Nes Municipality,Norway;9.Department of Orthopaedics,Leiden University Medical Center,Leiden,The Netherlands
Abstract:

Background

Previous research indicates that people with osteoarthritis (OA) are not receiving the recommended and optimal treatment. Based on international treatment recommendations for hip and knee OA and previous research, the SAMBA model for integrated OA care in Norwegian primary health care has been developed. The model includes physiotherapist (PT) led patient OA education sessions and an exercise programme lasting 8–12 weeks. This study aims to assess the effectiveness, feasibility, and costs of a tailored strategy to implement the SAMBA model.

Methods/design

A cluster randomized controlled trial with stepped wedge design including an effect, process, and cost evaluation will be conducted in six municipalities (clusters) in Norway. The municipalities will be randomized for time of crossover from current usual care to the implementation of the SAMBA model by a tailored strategy. The tailored strategy includes interactive workshops for general practitioners (GPs) and PTs in primary care covering the SAMBA model for integrated OA care, educational material, educational outreach visits, feedback, and reminder material. Outcomes will be measured at the patient, GP, and PT levels using self-report, semi-structured interviews, and register based data. The primary outcome measure is patient-reported quality of care (OsteoArthritis Quality Indicator questionnaire) at 6-month follow-up. Secondary outcomes include referrals to PT, imaging, and referrals to the orthopaedic surgeon as well as participants’ treatment satisfaction, symptoms, physical activity level, body weight, and self-reported and measured lower limb function. The actual exposure to the tailor made implementation strategy and user experiences will be measured in a process evaluation. In the economic evaluation, the difference in costs of usual OA care and the SAMBA model for integrated OA care will be compared with the difference in health outcomes and reported by the incremental cost-effectiveness ratio (ICER).

Discussion

The results from the present study will add to the current knowledge on tailored strategies, which aims to improve the uptake of evidence-based OA care recommendations and improve the quality of OA care in primary health care. The new knowledge can be used in national and international initiatives designed to improve the quality of OA care.

Trial registration

ClinicalTrials.gov NCT02333656
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号